Should GLP1 R agonists be used as first line glucose lowering agents in patients with ESKD and DM2?
Answer from: at Community Practice
This is a great question, but like all clinical questions the answer will be "it depends". A provider considering adding a new drug for DM2 in a patient with CKD5/dialysis would need to know several specifics about the patient. Let's say, the patient is not on any DM2 medication. Is this an older, t...
Comments
For stages 3-4, sglt2 drugs are preferred especial...
at Northwestern University Endocrinology With Stage 3-4 CKD, SGLT2 inhibitors have a signif...
For stages 3-4, sglt2 drugs are preferred especial...
With Stage 3-4 CKD, SGLT2 inhibitors have a signif...